|
1
|
Chia VM, Newcomb PA, Bigler J, Morimoto
LM, Thibodeau SN and Potter JD: Risk of microsatellite-unstable
colorectal cancer is associated jointly with smoking and
nonsteroidal anti-inflammatory drug use. Cancer Res. 66:6877–6883.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou Y, Feng X, Liu YL, Ye SC, Wang H, Tan
WK, Tian T, Qiu YM and Luo HS: Down-regulation of miR-126 is
associated with colorectal cancer cells proliferation, migration
and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling
pathways. PLoS One. 8:e812032013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen Z, He X, Xia W, Huang Q, Zhang Z, Ye
J, Ni C, Wu P, Wu D, Xu J, et al: Prognostic value and
clinicopathological differences of HIFs in colorectal cancer:
Evidence from meta-analysis. PLoS One. 8:e803372013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo Y, Meng X, Wang Q, Wang Y and Shang H:
The ING4 binding with p53 and induced p53 acetylation were
attenuated by human papillomavirus 16 E6. PLoS One. 8:e714532013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li J and Li G: Cell cycle regulator ING4
is a suppressor of melanoma angiogenesis that is regulated by the
metastasis suppressor BRMS1. Cancer Res. 70:10445–10453. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Byron SA, Min E, Thal TS, Hostetter G,
Watanabe AT, Azorsa DO, Little TH, Tapia C and Kim S: Negative
regulation of NF-κB by the ING4 tumor suppressor in breast cancer.
PLoS One. 7:e468232012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Culurgioni S, Muñoz IG, Moreno A, Palacios
A, Villate M, Palmero I, Montoya G and Blanco FJ: Crystal structure
of inhibitor of growth 4 (ING4) dimerization domain reveals
functional organization of ING family of chromatin-binding
proteins. J Biol Chem. 287:10876–10884. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Palacios A, Moreno A, Oliveira BL, Rivera
T, Prieto J, Garcia P, Fernández-Fernández MR, Bernadó P, Palmero I
and Blanco FJ: The dimeric structure and the bivalent recognition
of H3K4me3 by the tumor suppressor ING4 suggests a mechanism for
enhanced targeting of the HBO1 complex to chromatin. J Mol Biol.
396:1117–1127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
You Q, Wang XS, Fu SB and Jin XM:
Downregulated expression of inhibitor of growth 4 (ING4) in
advanced colorectal cancers: A non-randomized experimental study.
Pathol Oncol Res. 17:473–477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang WC, Chan SH, Jang TH, Chang JW, Ko
YC, Yen TC, Chiang SL, Chiang WF, Shieh TY, Liao CT, et al:
miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral
squamous cell carcinoma invasion and metastasis. Cancer Res.
74:751–764. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen D, Chen Z, Jin Y, Dragas D, Zhang L,
Adjei BS, Wang A, Dai Y and Zhou X: MicroRNA-99 family members
suppress Homeobox A1 expression in epithelial cells. PLoS One.
8:e806252013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sugihara H, Ishimoto T, Watanabe M,
Sawayama H, Iwatsuki M, Baba Y, Komohara Y, Takeya M and Baba H:
Identification of miR-30e* regulation of Bmi1 expression mediated
by tumor-associated macrophages in gastrointestinal cancer. PLoS
One. 8:e818392013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang X, Zhu W, Zhang J, Huo S, Zhou L, Gu
Z and Zhang M: MicroRNA-650 targets ING4 to promote gastric cancer
tumorigenicity. Biochem Bioph Res Commun. 395:275–280. 2010.
View Article : Google Scholar
|
|
15
|
Feng L, Xie Y, Zhang H and Wu Y:
Down-regulation of NDRG2 gene expression in human colorectal cancer
involves promoter methylation and microRNA-650. Biochem Bioph Res
Commun. 406:534–538. 2011. View Article : Google Scholar
|
|
16
|
Zeng ZL, Li FJ, Gao F, Sun DS and Yao L:
Upregulation of miR-650 is correlated with down-regulation of ING4
and progression of hepatocellular carcinoma. J Surg Oncol.
107:105–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bartley AN, Yao H, Barkoh BA, Ivan C,
Mishra BM, Rashid A, Calin GA, Luthra R and Hamilton SR: Complex
patterns of altered MicroRNA expression during the
adenoma-adenocarcinoma sequence for microsatellite-stable
colorectal cancer. Clin Cancer Res. 17:7283–7293. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peres TV, Pedro DZ, de Cordova FM, Lopes
MW, Goncalves FM, Mendes-de-Aguiar CB, Walz R, Farina M, Aschner M
and Leal RB: In vitro manganese exposure disrupts MAPK signaling
pathways in striatal and hippocampal slices from immature rats.
Biomed Res Int. 2013:7692952013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thomas GM and Huganir RL: MAPK cascade
signalling and synaptic plasticity. Nat Rev Neurosci. 5:173–183.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cargnello M and Roux PP: Activation and
function of the MAPKs and their substrates, the MAPK-activated
protein kinases. Microbiol Mol Biol Rev. 75:50–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo G, Yao W, Zhang Q and Bo Y: Oleanolic
acid suppresses migration and invasion of malignant glioma cells by
inactivating MAPK/ERK signaling pathway. PLoS One. 8:e720792013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su N, Peng L, Xia B, Zhao Y, Xu A, Wang J,
Wang X and Jiang B: Lyn is involved in CD24-induced ERK1/2
activation in colorectal cancer. Mol Cancer. 11:432012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gout S, Morin C, Houle F and Huot J: Death
receptor-3, a new E-Selectin counter-receptor that confers
migration and survival advantages to colon carcinoma cells by
triggering p38 and ERK MAPK activation. Cancer Res. 66:9117–9124.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen L, Li M, Li Q, Wang CJ and Xie SQ:
DKK1 promotes hepatocellular carcinoma cell migration and invasion
through β-catenin/MMP7 signaling pathway. Mol Cancer. 12:1572013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Scanlon CS, van Tubergen EA, Inglehart RC
and D'Silva NJ: Biomarkers of epithelial-mesenchymal transition in
squamous cell carcinoma. J Dent Res. 92:114–121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Parri M and Chiarugi P: Rac and Rho
GTPases in cancer cell motility control. Cell Commun Signal.
8:232010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metast Rev.
28:15–33. 2009. View Article : Google Scholar
|
|
28
|
Slaby O, Svoboda M, Michalek J and Vyzula
R: MicroRNAs in colorectal cancer: Translation of molecular biology
into clinical application. Mol Cancer. 8:1022009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mraz M, Dolezalova D, Plevova K, Stano
Kozubik K, Mayerova V, Cerna K, Musilova K, Tichy B, Pavlova S,
Borsky M, et al: MicroRNA-650 expression is influenced by
immunoglobulin gene rearrangement and affects the biology of
chronic lymphocytic leukemia. Blood. 119:2110–2113. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zuo ZH, Yu YP, Ding Y, Liu S, Martin A,
Tseng G and Luo JH: Oncogenic activity of miR-650 in prostate
cancer is mediated by suppression of CSR1 expression. Am J Pathol.
185:1991–1999. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Garkavtsev I, Kozin SV, Chernova O, Xu L,
Winkler F, Brown E, Barnett GH and Jain RK: The candidate tumour
suppressor protein ING4 regulates brain tumour growth and
angiogenesis. Nature. 428:328–332. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li X, Cai L, Liang M, Wang Y, Yang J and
Zhao Y: ING4 induces cell growth inhibition in human lung
adenocarcinoma A549 cells by means of Wnt-1/beta-catenin signaling
pathway. Anat Rec (Hoboken). 291:593–600. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li S, Fan T, Liu H, Chen J, Qin C and Ren
X: Tumor suppressor ING4 overexpression contributes to
proliferation and invasion inhibition in gastric carcinoma by
suppressing the NF-kappaB signaling pathway. Mol Biol Rep.
40:5723–5732. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li J, Martinka M and Li G: Role of ING4 in
human melanoma cell migration, invasion and patient survival.
Carcinogenesis. 29:1373–1379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hung T, Binda O, Champagne KS, Kuo AJ,
Johnson K, Chang HY, Simon MD, Kutateladze TG and Gozani O: ING4
mediates crosstalk between histone H3 K4 trimethylation and H3
acetylation to attenuate cellular transformation. Mol Cell.
33:248–256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lou C, Jiang S, Guo X and Dong XS: ING4 is
negatively correlated with microvessel density in colon cancer.
Tumour Biol. 33:2357–2364. 2012. View Article : Google Scholar : PubMed/NCBI
|
